NF-κB (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "NF-κB" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

7oadoi.org

799^th place

22^nd place

7doi.org

2^nd place

7^th place

2web.archive.org

1^st place

1jimmunol.org

low place

doi.org

dx.doi.org

TD. Gilmore, The Rel/NF-κB signal transduction pathway: introduction., in Oncogene, vol. 18, n. 49, novembre 1999, pp. 6842-4, DOI:10.1038/sj.onc.1203237, PMID 10602459.
BC. Albensi, MP. Mattson, Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity., in Synapse, vol. 35, n. 2, febbraio 2000, pp. 151-9, DOI:10.1002/(SICI)1098-2396(200002)35:2151::AID-SYN83.0.CO;2-P, PMID 10611641.
R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences., in Cell, vol. 46, n. 5, agosto 1986, pp. 705-16, DOI:10.1016/0092-8674(86)90346-6, PMID 3091258.
Garg A, Aggarwal BB, Nuclear transcription factor-kappaB as a target for cancer drug development, in Leukemia, vol. 16, n. 6, giugno 2002, pp. 1053–68, DOI:10.1038/sj.leu.2402482, PMID 12040437.
Sethi G, Sung B, Aggarwal BB, Nuclear factor-kappaB activation: from bench to bedside, in Exp. Biol. Med. (Maywood), vol. 233, n. 1, gennaio 2008, pp. 21–31, DOI:10.3181/0707-MR-196, PMID 18156302.
Hamdy NA, Denosumab: RANKL inhibition in the management of bone loss, in Drugs Today (Barc)., vol. 44, n. 1, 2008, pp. 7–21, DOI:10.1358/dot.2008.44.1.1178467, PMID 18301800.
Cvek B, Dvorak Z, Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals, in Curr. Pharm. Des., vol. 13, n. 30, 2007, pp. 3155–67, DOI:10.2174/138161207782110390, PMID 17979756.

jimmunol.org

(EN) S. P. Hehner, T. G. Hofmann, W. Dröge and M. Lienhard Schmitz, The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex, in The Journal of Immunology, vol. 163, n. 10, 1999, pp. 5617-5623. PDF

nih.gov

ncbi.nlm.nih.gov

TD. Gilmore, The Rel/NF-κB signal transduction pathway: introduction., in Oncogene, vol. 18, n. 49, novembre 1999, pp. 6842-4, DOI:10.1038/sj.onc.1203237, PMID 10602459.
BC. Albensi, MP. Mattson, Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity., in Synapse, vol. 35, n. 2, febbraio 2000, pp. 151-9, DOI:10.1002/(SICI)1098-2396(200002)35:2151::AID-SYN83.0.CO;2-P, PMID 10611641.
R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences., in Cell, vol. 46, n. 5, agosto 1986, pp. 705-16, DOI:10.1016/0092-8674(86)90346-6, PMID 3091258.
(EN) NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) RELA v-rel reticuloendotheliosis viral oncogene homolog A (avian) [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) RELB v-rel reticuloendotheliosis viral oncogene homolog B [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) REL v-rel reticuloendotheliosis viral oncogene homolog (avian) [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
Garg A, Aggarwal BB, Nuclear transcription factor-kappaB as a target for cancer drug development, in Leukemia, vol. 16, n. 6, giugno 2002, pp. 1053–68, DOI:10.1038/sj.leu.2402482, PMID 12040437.
Sethi G, Sung B, Aggarwal BB, Nuclear factor-kappaB activation: from bench to bedside, in Exp. Biol. Med. (Maywood), vol. 233, n. 1, gennaio 2008, pp. 21–31, DOI:10.3181/0707-MR-196, PMID 18156302.
Vlahopoulos S, Boldogh I, Casola A, Brasier AR, Nuclear factor-κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation, in Blood, vol. 94, n. 6, settembre 1999, pp. 1878–89, PMID 10477716. URL consultato il 24 aprile 2012 (archiviato dall'url originale il 12 settembre 2019).
Hamdy NA, Denosumab: RANKL inhibition in the management of bone loss, in Drugs Today (Barc)., vol. 44, n. 1, 2008, pp. 7–21, DOI:10.1358/dot.2008.44.1.1178467, PMID 18301800.
Cvek B, Dvorak Z, Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals, in Curr. Pharm. Des., vol. 13, n. 30, 2007, pp. 3155–67, DOI:10.2174/138161207782110390, PMID 17979756.

oadoi.org

TD. Gilmore, The Rel/NF-κB signal transduction pathway: introduction., in Oncogene, vol. 18, n. 49, novembre 1999, pp. 6842-4, DOI:10.1038/sj.onc.1203237, PMID 10602459.
BC. Albensi, MP. Mattson, Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity., in Synapse, vol. 35, n. 2, febbraio 2000, pp. 151-9, DOI:10.1002/(SICI)1098-2396(200002)35:2151::AID-SYN83.0.CO;2-P, PMID 10611641.
R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences., in Cell, vol. 46, n. 5, agosto 1986, pp. 705-16, DOI:10.1016/0092-8674(86)90346-6, PMID 3091258.
Garg A, Aggarwal BB, Nuclear transcription factor-kappaB as a target for cancer drug development, in Leukemia, vol. 16, n. 6, giugno 2002, pp. 1053–68, DOI:10.1038/sj.leu.2402482, PMID 12040437.
Sethi G, Sung B, Aggarwal BB, Nuclear factor-kappaB activation: from bench to bedside, in Exp. Biol. Med. (Maywood), vol. 233, n. 1, gennaio 2008, pp. 21–31, DOI:10.3181/0707-MR-196, PMID 18156302.
Hamdy NA, Denosumab: RANKL inhibition in the management of bone loss, in Drugs Today (Barc)., vol. 44, n. 1, 2008, pp. 7–21, DOI:10.1358/dot.2008.44.1.1178467, PMID 18301800.
Cvek B, Dvorak Z, Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals, in Curr. Pharm. Des., vol. 13, n. 30, 2007, pp. 3155–67, DOI:10.2174/138161207782110390, PMID 17979756.

web.archive.org

Vlahopoulos S, Boldogh I, Casola A, Brasier AR, Nuclear factor-κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation, in Blood, vol. 94, n. 6, settembre 1999, pp. 1878–89, PMID 10477716. URL consultato il 24 aprile 2012 (archiviato dall'url originale il 12 settembre 2019).
Role of RCP006 as an anti-inflammatory agent, su rfdn.org, Roskamp Institute. URL consultato il 6 settembre 2011 (archiviato dall'url originale il 23 ottobre 2011).